Ortho Clinical Diagnostics (OCD), in partnership with the National Association of Chronic Disease Directors (NACDD), today unveiled new consumer survey results and a report revealing the state of blood test health literacy in the United States with strategies to support much-needed patient education and empowerment. The first step: ensuring patient access to and understanding of blood test results, a critical component to maintaining health and wellness. The campaign kicks off during National Health Literacy Month, an awareness effort founded in 1999 to promote the importance of understandable health information.
To view Multimedia News Release, go to http://www.multivu.com/mnr/52662-ortho-clinical-diagnostics-and-nacdd-blood-test-health-literacy-survey
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, today announced it has received U.S. Food and Drug Administration (FDA) clearance for the ClearSight system.
The ClearSight system is a noninvasive monitor that provides clinicians access to valuable blood volume and blood flow information for patients at moderate or high risk of post-surgical complications, in whom invasive monitoring would not be used.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7256451-edwards-fda-clearance-for-noninvasive-hemodynamic-monitoring-system/
Al-Dura Calls Children to follow him to Paradise Clip PATV 2000-2003 PATV June 28, 2006 "I am waving to you, not in parting, but to say follow me" Muhammad al-Dura How sweet is the fragrance of the martyrs. How sweet is the fragrance of the earth its thirst quenched by the gush of blood flowing from the youthful body How sweet is the fragrance of the martyrs O father, till we meet till we meet O father, till we meet
(more)
Ruby dreams of love and escaping the Congregation. But if Ruby leaves, the Congregation will die without the secret ingredient to the Water, her blood. So she stays, and prays to their savior Otto, who first gave Water to the Congregants, and fathered Ruby before he vanished. Learn more about this book here, http://bit.ly/eqpEJw and its author here, http://www.pambachorz.com YA
The Leukemia & Lymphoma Society (LLS) today announced it has committed $28.6 million in new research investment to advance the most promising blood cancer science at leading academic and medical institutions around the world, including Dana-Farber Cancer Institute, Weill Cornell Medical College and MD Anderson Cancer Center. As LLS leads the charge to find cures for cancer patients, this new funding, along with ongoing investment in LLS’s aggressive research agenda, brings LLS’s total commitment to blood cancer research to more than $1 billion. The investment has led to the development of nearly every therapy currently used to treat the blood cancers.
Along with these new research grants, LLS remains committed to collaborating with biotechnology companies through its innovative Therapy Acceleration Program® (TAP), a model pioneered by LLS in the cancer arena in recognition that traditional research approaches weren’t yielding treatments and cures fast enough for patients. LLS commits approximately $13 million a year to its TAP initiatives. As part of the 24 current such collaborations, LLS recently initiated new investments with Kite Pharma and OncoPep.
To view the multimedia release go to:
http://www.multivu.com/players/English/7554852-lls-cancer-research-funding/
Joerns Healthcare has launched the Dolphin Fluid Immersion Simulation® system that more effectively prevents and treats pressure-related injuries than other surfaces. This patented technology simulates the effect of floating in water for patients on hospital beds, stretchers, and in wheel chairs. The Dolphin technology continually adjusts to the patient’s body, promoting tissue perfusion and oxygenation, and minimizing injury related to compromised blood flow. The Dolphin is also proven to accelerate healing of advanced stage or multiple pressure ulcers, muscle flaps, skin grafts, burns and other wound conditions.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58463-joerns-dolphin-fluid-immersion-simulation-system-pressure-related-injuries
Diet Coke and Heidi Klum are joining forces once again. For the third consecutive year Diet Coke is partnering with Klum and the National Heart, Lung, and Blood Institute (NHLBI) in a national heart health awareness campaign called The Heart Truth. To bring heart health into the spotlight during February, American Heart Month, Diet Coke will distribute special limited-edition packaging in support of the campaign. For her part, Klum will return to the runway for the Diet Coke sponsored Red Dress Collection Fashion Show on February 11, the popular kick-off to Mercedes-Benz Fashion Week in New York.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/cocacola/42212/
Diet Coke and Heidi Klum joined forces on February 1 to raise awareness and funds for women\'s heart health education and research. February is American Heart Month, and for the fourth consecutive year, Diet Coke is partnering with the National Heart, Lung, and Blood Institute to support The Heart Truth® campaign. This year, Diet Coke has created a national game of \
